11-64300858-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001039496.2(CATSPERZ):āc.223G>Cā(p.Glu75Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000223 in 1,560,110 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001039496.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CATSPERZ | ENST00000328404.8 | c.223G>C | p.Glu75Gln | missense_variant | 2/5 | 1 | NM_001039496.2 | ENSP00000491717.1 | ||
KCNK4-TEX40 | ENST00000539086.5 | n.2230G>C | non_coding_transcript_exon_variant | 8/11 | 1 | |||||
CATSPERZ | ENST00000539943.1 | c.97G>C | p.Glu33Gln | missense_variant | 1/4 | 2 | ENSP00000443917.1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152252Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000989 AC: 16AN: 161800Hom.: 0 AF XY: 0.000126 AC XY: 11AN XY: 87332
GnomAD4 exome AF: 0.000234 AC: 329AN: 1407740Hom.: 1 Cov.: 32 AF XY: 0.000234 AC XY: 163AN XY: 695426
GnomAD4 genome AF: 0.000125 AC: 19AN: 152370Hom.: 0 Cov.: 33 AF XY: 0.0000805 AC XY: 6AN XY: 74518
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 05, 2024 | The c.223G>C (p.E75Q) alteration is located in exon 2 (coding exon 2) of the TEX40 gene. This alteration results from a G to C substitution at nucleotide position 223, causing the glutamic acid (E) at amino acid position 75 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at